Internal Medicine, Pulmonary Disease · Nederland, TX
NPI
1396037008
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2300 Highway 365 Ste 150
Nederland, TX, 77627
Phone (409) 401-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$462K
6,527 services
Medicare patients, 2024
378
Average age 73
Drug cost, 2024
$8.2M
6,890 prescriptions
Company payments, 2025
$9,202
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roozbeh Sharif was code 99215 (office e&m - established), 915 times for 259 patients. In total Roozbeh Sharif billed 6,527 services in 61 codes, and Medicare paid $462K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 915 | 259 | $129.30 | $118K |
| 99291 Critical Care E&M | Facility | 770 | 96 | $159.29 | $123K |
| 94375 Pulmonary Function Testing | Office | 474 | 202 | $27.82 | $13K |
| 94618 Pulmonary Function Testing | Office | 442 | 234 | $24.98 | $11K |
| 94729 Pulmonary Function Testing | Office | 357 | 245 | $39.78 | $14K |
| 94726 Pulmonary Function Testing | Office | 350 | 244 | $39.73 | $14K |
| 36415 Venipuncture Blood Collection | Office | 339 | 167 | $8.62 | $2,924 |
| 99212 Office E&M - Established | Office | 328 | 159 | $41.11 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 289 | 63 | $86.11 | $25K |
| 94060 Pulmonary Function Testing | Office | 276 | 214 | $27.52 | $7,594 |
| 94450 Pulmonary Function Testing | Office | 220 | 134 | $56.28 | $12K |
| 99214 Office E&M - Established | Office | 182 | 111 | $91.54 | $17K |
| 94010 Pulmonary Function Testing | Office | 177 | 126 | $19.70 | $3,487 |
| 99205 Office E&M - New | Office | 147 | 146 | $159.17 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 119 | 52 | $58.17 | $6,923 |
By year: 2022 $495K for 6,601 services; 2023 $475K for 5,770 services; 2024 $462K for 6,527 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 339 | 167 | $8.62 | $2,924 |
Medicare prescription drug claims, 2024
In 2024, the drug Roozbeh Sharif prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,117 prescriptions and refills. In total Roozbeh Sharif wrote 6,890 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,117 | 1,321 | 402 | $24K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,058 | 1,226 | 295 | $743K |
| Montelukast Sodium Generic | 962 | 1,719 | 311 | $6,832 |
| Furosemide Generic | 557 | 933 | 189 | $1,784 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 383 | 434 | 153 | $263K |
| Prednisone Generic | 312 | 331 | 190 | $663 |
| Dupixent Pen Dupilumab | 216 | 227 | 45 | $873K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 196 | 196 | 133 | $2,252 |
| Breo Ellipta Fluticasone/Vilanterol | 183 | 219 | 54 | $84K |
| Ofev Nintedanib Esylate | 177 | 179 | 53 | $2.3M |
| Metolazone Generic | 80 | 120 | 34 | $1,347 |
| Symbicort Budesonide/Formoterol Fumarate | 76 | 88 | 24 | $20K |
| Tyvaso Dpi Treprostinil | 65 | 67 | Under 11 | $1.6M |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 64 | 74 | 15 | $6,589 |
| Sildenafil Citrate Generic | 60 | 94 | 13 | $7,592 |
Brand drugs: - claims; generic drugs: 3,664 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roozbeh Sharif $9,202 ($9,202 in general payments such as food, travel and fees) from 18 companies. The largest payer was United Therapeutics Corporation with $6,483.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 13 | $6,483 |
| Verona Pharma, Inc. VRNA | 9 | $1,123 |
| GlaxoSmithKline, LLC. GSK | 16 | $320 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $243 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $167 |
| Genzyme Corporation SNY | 13 | $164 |
| Merck Sharp & Dohme LLC MRK | 6 | $140 |
| Electromed, Inc. ELMD | 11 | $127 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $103 |
| Philips North America LLC PHG | 5 | $88.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.